← Eichor
Study identifier: NCT07084480 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Giant Cell Arteritis - Ways to Precision Medicine

Condition: Giant Cell Arteritis · Polymyalgia Rheumatic (PMR)  ·  Sponsor: Wuerzburg University Hospital

PhaseN/A
Planned participants400
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Long-term follow-up of aortal adverse events, as well as glucocortioid-associated adverse events in patients with polymyalgia rheumatica (PMR) and giant cell arteritis (GCA).

This description comes directly from the study's public registry record.

Talk to the study team

Michael Gernert  ·  +4993120140100  ·  gernert_m1@ukw.de

Hannah Labinsky  ·  +4993120140100  ·  Labinsky_h@ukw.de

Always discuss trial participation with your own doctor first.

Locations (1)

Universitätsklinikum WürzburgWürzburg, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07084480